Anhui Sunhere Pharmaceutical Excipients Co Ltd (300452) — Net Asset Quality Index
Anhui Sunhere Pharmaceutical Excipients Co Ltd (300452) has a Net Asset Quality Index of 63.9% as of March 2026. This metric measures the proportion of total assets financed by shareholders' equity — total assets of CN¥1.76 Billion minus total liabilities of CN¥635.27 Million yields net assets of CN¥1.12 Billion. A higher index indicates a stronger, lower-leverage balance sheet. See defensive interval ratio of Anhui Sunhere Pharmaceutical Excipients to measure how many days the company can operate on defensive assets alone.
Quality Index
Net Assets
Total Assets
Total Liabilities
Anhui Sunhere Pharmaceutical Excipients Co Ltd Net Asset Quality Index Over Time (2011–2025)
This chart shows how Anhui Sunhere Pharmaceutical Excipients Co Ltd's Net Asset Quality Index has evolved across 15 annual periods from 2011 to 2025. As of March 2026, the index stands at 63.9%, representing net assets of CN¥1.12 Billion against total assets of CN¥1.76 Billion CNY. Explore Anhui Sunhere Pharmaceutical Excipients cash conversion from operations to assess how effectively this company generates cash.
Annual Net Asset Quality Index for Anhui Sunhere Pharmaceutical Excipients Co Ltd (2011–2025)
The table below presents the year-by-year Net Asset Quality Index for Anhui Sunhere Pharmaceutical Excipients Co Ltd from 2011 to 2025, covering 15 annual filings. Each row shows total assets, total liabilities, net assets, the quality index percentage, and the change in percentage points compared to the prior year. For market capitalisation and the full company profile, see market value of Anhui Sunhere Pharmaceutical Excipients .
| Year | Quality Index | Net Assets (CNY) | Total Assets | Total Liabilities | Change (pp) |
|---|---|---|---|---|---|
| 2025 | 62.7% | CN¥1.07 Billion | CN¥1.71 Billion | CN¥639.20 Million | ▲ +0.2 pp |
| 2024 | 62.5% | CN¥975.30 Million | CN¥1.56 Billion | CN¥584.43 Million | ▲ +1.9 pp |
| 2023 | 60.6% | CN¥935.25 Million | CN¥1.54 Billion | CN¥607.46 Million | ▼ -6.2 pp |
| 2022 | 66.8% | CN¥788.62 Million | CN¥1.18 Billion | CN¥391.93 Million | ▼ -6.5 pp |
| 2021 | 73.3% | CN¥705.92 Million | CN¥962.58 Million | CN¥256.67 Million | ▲ +0.6 pp |
| 2020 | 72.7% | CN¥655.17 Million | CN¥900.87 Million | CN¥245.70 Million | ▼ -0.9 pp |
| 2019 | 73.6% | CN¥596.57 Million | CN¥810.17 Million | CN¥213.59 Million | ▼ -5.0 pp |
| 2018 | 78.6% | CN¥557.89 Million | CN¥709.75 Million | CN¥151.86 Million | ▲ +3.5 pp |
| 2017 | 75.1% | CN¥500.23 Million | CN¥666.40 Million | CN¥166.17 Million | ▼ -3.5 pp |
| 2016 | 78.5% | CN¥402.70 Million | CN¥512.85 Million | CN¥110.15 Million | ▼ -0.8 pp |
| 2015 | 79.3% | CN¥363.20 Million | CN¥458.06 Million | CN¥94.86 Million | ▲ +12.8 pp |
| 2014 | 66.5% | CN¥177.20 Million | CN¥266.39 Million | CN¥89.19 Million | ▲ +2.6 pp |
| 2013 | 63.9% | CN¥149.23 Million | CN¥233.58 Million | CN¥84.35 Million | ▲ +6.8 pp |
| 2012 | 57.1% | CN¥121.17 Million | CN¥212.20 Million | CN¥91.03 Million | ▼ -21.9 pp |
| 2011 | 79.0% | CN¥95.96 Million | CN¥121.51 Million | CN¥25.55 Million | — |